Aim: To determine absolute and relative risks of all-cause and cardiovascular mortality among patients newly diagnosed with type 2 diabetes. Methods: In an observational cohort study using record-linkage databases, based in Tayside, Scotland, UK, we identified newly diagnosed patients with type 2 diabetes in 1993-2004. We also identified a set of nondiabetic comparators from lists of patients registered with General Practice, individually matched to the diabetic patients by sex, age and deprivation. We followed up patients for mortality and cardiovascular mortality over a 12 year period, and calculated hazard ratios (HRs) using Cox regression. Results: There were 10,532 patients with type 2 diabetes, and 21,056 non-diabetic comparators. Diabetic patients in every age/sex group had higher absolute mortality rates. Even taking deprivation into account, the HR for mortality was 1.32 (95% CI 1.25 to 1.40), decreasing to 1.15 (1.09 to 1.22) after adjusting for pre-existing cardiovascular disease. The HRs for cardiovascular mortality were higher, decreasing from 1.51 (1.37 to 1.67) to 1.23 (1.11 to 1.36) after adjusting for pre-existing cardiovascular disease. The HRs decreased with increasing age at diagnosis, although the difference in absolute rate of mortality increased slightly with age. Increased mortality risks were only evident two years after diagnosis and increased thereafter. Conclusions: Patients with type 2 diabetes have an increased risk of all-cause and cardiovascular mortality compared with non diabetic comparators, although this is not observable immediately after diagnosis. Age at diagnosis and duration of the disease independently affect absolute and relative mortality risk.
Introduction
Numerous studies have shown that type 2 diabetes reduces life expectancy [1] [2] [3] [4] mainly due to an increased risk of cardiovascular mortality 3 . Studies have suggested that patients with type 2 diabetes may have up to a three-fold increase in mortality compared with people without diabetes 3, 4 . However, many studies that have investigated mortality have taken a crosssectional sample of patients with type 2 diabetes at one point in time and followed them up for mortality. The published risks then represent the mean increased risks across heterogeneous groups of patients with varying disease duration and age of diagnosis. The increased mortality risk among patients newly diagnosed with type 2 diabetes is not well
documented. The few studies that have followed patients from diagnosis suggest that the relative risk of mortality associated with diabetes decreases with increasing age at diagnosis [5] [6] [7] [8] .
Published literature on cardiovascular mortality in newly diagnosed patients with type 2 diabetes is even less well documented, although a recent American study showed more than a two-fold increase in cardiovascular mortality in newly diagnosed older patients 9 . This study also found mortality risk to rise only two years after diagnosis and not increase thereafter, a finding that conflicts with studies that suggest that mortality rises with increasing duration of diabetes, independent of cardiovascular risk factors 10, 11 .
We used a diabetic clinical information system to follow up 10,532 patients newly diagnosed with type 2 diabetes in Tayside, Scotland and to evaluate the mortality risks associated with type 2 diabetes. We also investigated how age at diagnosis and disease duration affect allcause and cardiovascular mortality.
Methods
This observational cohort study was carried out among the resident population of Tayside holds information on all hospital admissions in Scotland from 1980.
We obtained the numbers of deaths for diabetic patients and non-diabetic comparators, stratified by sex and age at diagnosis. Cardiovascular deaths were identified as those that had a cardiovascular code for the underlying cause of death on the death certificate (codes defined above). We calculated absolute rates of all-cause and cardiovascular mortality by dividing the total numbers of deaths in each age/sex group by the total number of days follow up (to the end of the study or to a participant's date of death). A Kaplan-Meier survival curve was constructed for diabetic and non-diabetic comparators and a Cox regression survival analysis was used to calculate unadjusted hazard ratios (HRs) for all-cause and cardiovascular mortality. Because not all patients were matched for postal sector, we adjusted the HRs for deprivation using the Carstairs score. Previous cardiovascular admission was also treated as a covariate. Because cause of death information was judged to be reliable only up to 9 th December 2004, note that this was the end-date for all analyses of cardiovascular mortality.
To examine differences in mortality risk associated with new-onset diabetes over follow up, adjusted HRs were calculated for six follow up intervals, 0-2, 2-4, 4-6, 6-8 and 10-12 years for both all-cause mortality and cardiovascular mortality.
This study was granted ethical approval by the Tayside Committee for Medical Research Ethics. respectively. The absolute rates per 1,000 patient years are also shown in Table 1 and Figs 1 and 2.
Results

There
The higher absolute rates of all-cause mortality and cardiovascular mortality are clearly evident for patients with diabetes. All rates were higher for males, except the all-cause mortality rate among diabetic patients over 75 years. The difference in absolute rates of allcause mortality appeared to widen slightly among females and narrow slightly among males, as age increased. It is also notable that the widening of the absolute rates of cardiovascular mortality between diabetic patients and non-diabetic comparators appeared to occur slightly earlier among women than men.
A Cox regression survival analysis (adjusted for deprivation) showed that patients with type 2 diabetes had an increased HR (with 95% confidence intervals) of 1.32 (1.25 to 1.40) for mortality compared with non diabetic comparators, after adjusting for differences in deprivation between the groups (Table 2 ). However, after adjusting for previous cardiovascular admission, the risk reduced to 1.15 (1.09 to 1.22). The risks were very similar for men and women. The same patterns were observed for cardiovascular mortality, although the HRs were slightly higher. The HRs for all-cause and cardiovascular mortality decreased with increasing age at diagnosis. In the age group 45-54 years, much higher HRs were observed among women compared to men, particularly for cardiovascular mortality. wide, there seems to be a trend for increasing risk of all-cause mortality with increasing duration of diabetes, reaching a peak between 6 and 8 years, and then decreasing. This trend is even more marked for cardiovascular mortality, but reaching a peak slightly earlier.
Conclusions
This study further supports the literature showing that type 2 diabetes reduces life expectancy [1] [2] [3] [4] . In general, patients with diabetes had higher absolute rates of all-cause and cardiovascular mortality than non-diabetic comparators, even when they were matched for deprivation levels (deprivation being an important confounder because deprived people are more likely to have diabetes 17 , and to have higher rates of mortality 18 ). Even after adjusting more fully for deprivation and for previous cardiovascular disease, increased risks of allcause and cardiovascular mortality associated with type 2 diabetes were still apparent. These risks were much lower than those reported in cross-sectional studies 3, 4 , not only because we adjusted for deprivation, but probably also because our longitudinal design among a clearly defined cohort of newly diagnosed patients, provides a more accurate estimate of risk.
In general, the differences in absolute rate between diabetic patients and their comparators widened slightly as age at diagnosis increased. Despite this, the hazard ratios decreased with increasing age of diagnosis. No increased risk associated with type 2 diabetes was observed among very old men (over the age of 75 years), as has been observed previously 5 . This is also consistent with a diminishing reduction in life expectancy identified among patients with increasing age of diagnosis in a cross-sectional sample 19 . However, this result is slightly misleading in that the increased risk associated with diabetes is deemed to be low (as defined by the hazard ratio) when compared with a very high background mortality rate (among older people) and is deemed to be high when compared with a low background mortality rate (among younger people). While a young person diagnosed with type 2 diabetes has a very high HR for all-cause mortality, their absolute rate is still relatively low because the background rate is low. The converse applies to older people. The HR is relatively low but diabetes is still associated with a large number of deaths because the background rate is high.
It is therefore important that clinicians understand and are able to communicate measures of risk appropriately 20 .
Similar patterns were observed for cardiovascular mortality. The risks observed were lower than those found in other studies 9 , perhaps because we matched and further adjusted for deprivation. The effect of pre-existing cardiovascular disease on the risk of all-cause and cardiovascular mortality is also clearly shown, with HRs decreasing substantially after adjusting for this covariate, particularly for cardiovascular mortality (as might be expected).
There were no data available for classic cardiovascular risk factors (BMI, blood pressure, serum lipids, smking) so it was not possible to determine to what extent this increased cardiovascular risk could be explained by these factors. Also, we may not have fully adjusted for pre-existing cardiovascular disease for those patients who had never been hospitalized.
However, this effect is likely to be small.
This study provides further evidence that diabetes confers a greater increased risk of cardiovascular mortality among younger women (aged 45-64 years) compared with men of the same age. This has been observed in other studies 21, 22 , and more adverse cardiovascular risk profiles among women, but more aggressive treatment for men, has been one explanation for the difference. However, a meta-analysis found no difference between men and women after adjusting for cardiovascular risk factors 23 . We still found high risks of cardiovascular mortality among younger women even after adjusting for previous cardiovascular disease (but not other cardiovascular risk factors). Nevertheless, although in general men have higher cardiovascular mortality rates and the actual numbers of deaths associated with diabetes are higher in men than women 23 , the impact of diabetes on mortality risk in younger women should not be under-estimated.
In this study, we identified almost no adverse effect on all-cause or cardiovascular mortality during the first two years after diagnosis with diabetes (after adjusting for previous cardiovascular risk), but then a trend for increased risk with increasing duration. This declined after about eight years. Our results are therefore compatible with the hypothesis that long-term hyperglycaemia leads to atherosclerosis, and that the detrimental effects on mortality are not immediately evident after diagnosis, especially given that many people have diabetes undetected for a number of years before clinical diagnosis 24 . In contrast, a study from the US suggested that increased risk of all-cause and cardiovascular mortality was elevated immediately after diagnosis and did not appear to increase with time 9 . Note though that this US study was among only 282 older patients (over 65 years) and the confidence intervals were wide. A UK study found an increased risk of mortality during the first five years after diagnosis, but did not break down the risks within this period 25 . However, neither study adjusted for pre-existing cardiovascular disease.
We are confident that the data used have produced an accurate measure of the effect of type 2 diabetes on mortality risk. The DARTS clinical information system has high sensitivity at identifying patients with diabetes. Ascertainment of mortality relied on a validated national 
